Kraig Biocraft Laboratories Inc (KBLB): “We’re proud to be working with the Depa...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Kraig Biocraft Laboratories Inc (KBLB)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	133
Posts	24242
Boards Moderated	6
Alias Born	03/03/2013

Re: Spillmonkey post# 109213

Saturday, 07/23/2016 7:56:20 AM

Saturday, July 23, 2016 7:56:20 AM

“We’re proud to be working with the Department of Defense to assess the exciting potential of spider silk for military applications,” stated Kim K Thompson, CEO and founder of Kraig Biocraft Laboratories.

“We are honored that the U.S. Army has selected us for this program. This effort will provide Kraig Labs with the opportunity to validate our longstanding belief that spider silk technology has had an incredible potential for protective and lifesaving materials and expand our ability to design and engineer innovative materials solutions.”

Blessings to All

TRUTH

I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent KBLB News

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM

More KBLB News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow